Preferred
(EDT)
[Joint Session] Non-Alcoholic Fatty Liver Disease, Liver Inflammation and Fibrogenesis in the Pathogenesis of Hepatobiliary Cancers
11:10 AM - 1:00 PM EDT
Monday, March 22, 2021Room: Multi Tech Session Other
[Joint Session] Non-Alcoholic Fatty Liver Disease, Liver Inflammation and Fibrogenesis in the Pathogenesis of Hepatobiliary Cancers
A TGF-ß-ALDH2 Axis in Obesity, Metabolic Syndrome, and HCC
11:10 AM - 11:35 AM EDT
Monday, March 22, 2021Room: V300 Guy Coombes Speaker
Lopa Mishra, MD
George Washington University
[Joint Session] Non-Alcoholic Fatty Liver Disease, Liver Inflammation and Fibrogenesis in the Pathogenesis of Hepatobiliary Cancers
Coffee Break
11:35 AM - 11:55 AM EDT
Monday, March 22, 2021[Joint Session] Non-Alcoholic Fatty Liver Disease, Liver Inflammation and Fibrogenesis in the Pathogenesis of Hepatobiliary Cancers
The Gut-Liver Axis in Liver Cancer Risk Conditions
11:55 AM - 12:20 PM EDT
Monday, March 22, 2021Room: V200 Ronney Laws Speaker
Maria Rescigno, PhD
Humanitas University
[Joint Session] Non-Alcoholic Fatty Liver Disease, Liver Inflammation and Fibrogenesis in the Pathogenesis of Hepatobiliary Cancers
Lipid Dysregulation in Inflammation, NASH, and Cancer
12:20 PM - 12:45 PM EDT
Monday, March 22, 2021Room: V200 Ronney Laws Speaker
Daniel Heller, PhD
Memorial Sloan Kettering Cancer Center
[Joint Session] Non-Alcoholic Fatty Liver Disease, Liver Inflammation and Fibrogenesis in the Pathogenesis of Hepatobiliary Cancers
Short Talk: The α1-Na/K-ATPase/Src-p/PI3K Pathway Modulates the Survivin-SMAC Apoptotic “Switch” in NASH Related Hepatocellular Carcinoma: A Translational Study
12:45 PM - 1:00 PM EDT
Monday, March 22, 2021Room: V200 Ronney Laws Speaker
Juan Sanabria, MD
Marshall University/Case Western Reserve University
[Joint Session] Non-Alcoholic Fatty Liver Disease, Liver Inflammation and Fibrogenesis in the Pathogenesis of Hepatobiliary Cancers
